0000001775
1
5
2
-
0
9
X
/
4
6
 
$
.
http
:
dx
doi
org
dmd
7
3
D
RUG
M
ETABOLISM
AND
ISPOSITION
Drug
Metab
Dispos
,
October
Copyright
a
by
The
American
Society
for
Pharmacology
and
Experimental
Therapeutics
Effects
of
Milk
Thistle
(
Silybum
marianum
)
on
Human
Cytochrome
P
Activity
Marina
Kawaguchi
Suzuki
Reginald
F
Frye
Hao
Jie
Zhu
Bryan
J
Brinda
Kenneth
Chavin
Hilary
Bernstein
John
S
Markowitz
Department
Pharmacotherapy
Translational
Research
K
R
B
{S}
Center
Pharmacogenomics
University
Florida
Gainesville
;
Clinical
Social
Administrative
Sciences
Michigan
College
Pharmacy
Ann
Arbor
H
Z
Surgery
Division
Transplantation
C
Psychiatry
Behavioral
Medical
South
Carolina
Charleston
Received
January
accepted
July
ABSTRACT
thistle
extracts
are
widely
used
as
complementary
alternative
treatment
various
hepatic
conditions
host
other
diseases
disorders
active
constituents
milk
supplements
believed
to
be
the
flavonolignans
contained
within
In
vitro
studies
have
suggested
that
some
components
may
significantly
inhibit
specific
cytochrome
enzymes
However
determining
potential
clinically
significant
drug
interactions
with
products
has
been
complicated
inconsistencies
between
in
vivo
study
results
aim
present
was
determine
effect
standardized
supplement
major
metabolizing
after
day
exposure
period
CYP
A
activities
were
measured
simultaneously
administering
four
probe
drugs
caffeine
tolbutamide
dextromethorphan
midazolam
nine
healthy
volunteers
before
extract
given
thrice
daily
days
three
most
abundant
falvonolignans
found
plasma
following
silybin
isosilybin
concentrations
these
individually
subjects
perpetrators
peak
areas
under
time
concentration
curves
determined
administration
Exposure
produced
no
influence
or
Introduction
one
commonly
botanical
world
today
US
sales
an
estimated
billion
USD
among
which
ranked
sixth
total
Lindstrom
et
al
crude
obtained
from
seeds
termed
silymarin
contains
complex
mixture
seven
silychristin
silydianin
flavonoid
together
account
8
%
composition
Kroll
Typically
oral
much
higher
systemic
circulation
relative
Silymarin
is
distinguished
silibinin
specifically
refers
semipurified
representing
approximately
purported
useful
liver
gallbladder
ailments
including
alcoholic
disease
acute
chronic
viral
hepatitis
toxin
induced
Choi
National
Toxicology
Program
Shi
Klotz
United
States
Europe
up
patients
use
preparations
Loguercio
Festi
Beyond
reported
hepatoprotectant
effects
also
shown
produce
generalized
antioxidant
antitumor
antiinflammatory
antifibrotic
antihyperglycemic
actions
As
consequence
widespread
treat
array
combined
conventional
medications
possibility
exists
s
prominent
phase
I
catalyze
oxidative
metabolism
wide
molecules
chemical
carcinogens
steroids
fatty
acids
Guengerich
isoenzymes
human
participate
over
marketed
Zanger
Schwab
Thus
any
alteration
can
lead
altered
clearance
many
This
work
supported
Institutes
Health
Complementary
Alternative
Medicine
[
Grant
AT
]
clinical
at
General
Resources
RR
ABBREVIATIONS
AUC
area
curve
max
CAF
CBC
complete
blood
count
CI
confidence
interval
DEX
DOR
dextrorphan
HCV
virus
HPLC
high
performance
liquid
chromatography
HPLCMS
MS
tandem
mass
spectrometry
IS
internal
standard
LLOQ
lower
limit
quantification
MDZ
NAFLD
nonalcoholic
OHMDZ
hydrozymidazolam
TOL
Because
concerns
exist
Several
individual
E
Beckmann
Knopp
Venkataramanan
Zuber
Sridar
Concentration
dependent
inhibition
mechanism
based
inactivation
silybins
Despite
apparent
ability
more
several
published
data
unable
replicate
predictions
Leber
Knauff
Piscitelli
DiCenzo
Gurley
b
Mills
van
Erp
Fuhr
Rao
Deng
recent
report
utilizing
microsomes
evaluated
number
inhibitors
identified
potent
inhibitor
IC
value
m
followed
Brantley
Isosilybin
noted
weaker
values
respectively
there
precedent
formulated
provide
enhanced
bioavailability
i
e
phosphatidylcholine
Flaig
previous
dose
escalation
assessing
pharmacokinetics
formulation
order
magnitude
less
than
even
lowest
objective
address
via
validated
combination
Materials
Methods
Study
Supplement
Legalon
capsules
MADAUS
GmbH
Cologne
Germany
this
Each
capsule
mg
dried
achenes
phytoconstituents
Javed
We
independently
analyzed
confirm
contents
biologically
stereoselective
chromatographic
spectrometric
assay
established
our
laboratory
applied
normal
volunteer
pharmacokinetic
same
indicated
each
product
lot
taxifolin
Subjects
After
provision
written
informed
consent
approved
'
Office
Integrity
SC
participated
fixed
open
label
All
participants
medical
history
physical
examination
performed
physician
Furthermore
satisfactory
evaluation
baseline
serum
chemistries
counts
electrocardiogram
urinalysis
establish
health
status
Additionally
urine
screen
nicotine
cotinine
pregnancy
test
females
subject
preceded
participation
nonsmokers
not
taking
prescription
counter
dietary
inclusive
vitamins
requested
abstain
grapefruit
juice
containing
beverages
ethanol
weeks
prior
during
genotyped
so
poor
metabolizers
excluded
Design
Administration
Phase
overnight
fast
admitted
assessment
activity
morning
indwelling
venous
catheter
placed
arm
facilitate
serial
sampling
At
AM
administered
previously
consisted
single
doses
Versed
Syrup
Roche
Laboratories
Nutley
NJ
Vivarin
GlaxoSmithKline
Triangle
Park
NC
Orinase
Pharmacia
Upjohn
Kalamazoo
MI
Robitussin
Maximum
Strength
Wyeth
Madison
Wang
Wohlfarth
ml
tap
water
To
reduce
variability
absorption
due
food
remained
fasted
state
hours
Standard
meals
then
served
registered
dietician
did
include
samples
hour
Time
points
collection
immediately
they
discharged
unit
returned
through
separate
venipuncture
collected
heparinized
tubes
Vacutainer
BD
Biosciences
Franklin
Lakes
stored
ice
until
centrifugation
degC
analysis
measurement
II
Following
minimum
washout
provided
supply
instructions
take
times
PM
dispensed
original
blister
packs
III
readmitted
postexposure
placement
intravenous
catheters
again
dosed
cocktail
described
"
identical
addition
all
consumed
meal
Finally
concomitantly
discharge
continued
additional
thereafter
extended
Follow
Up
final
draw
follow
assurance
safety
Chemicals
Reagents
equivalent
donated
Analytical
standards
Sigma
Aldrich
St
Louis
MO
purchased
Fluka
Chemical
Milwaukee
WI
d
hydroxymidazolam
Cerilliant
Round
Rock
TX
Toronto
ON
Canada
TLC
PharmaChem
Concord
using
system
consisting
Surveyor
autosampler
quaternary
pump
TSQ
Quantum
Discovery
triple
quadrupole
spectrometer
Thermo
Scientific
San
Jose
CA
metabolite
better
characterize
Plasma
quantified
extraction
electrospray
positive
Nolin
ng
accuracy
precision
Caffeine
liquidliquid
Karunathilake
Tolbutamide
Briefly
processed
protein
precipitation
centrifuge
l
g
acetonitrile
vortex
mixed
centrifuged
minutes
column
gradient
separation
Synergi
MAX
RP
Torrence
mm
mobile
phases
mM
ammonium
formate
formic
acid
started
changed
linearly
minute
held
back
z
transitions
monitored
ionization
mode
collision
energy
V
run
sample
retention
both
glycine
buffer
deuterated
briefly
ethyl
ether
Tubes
capped
vigorously
upper
layer
transferred
clean
glass
culture
tube
evaporated
stream
nitrogen
residue
reconstituted
Samples
vials
injected
into
temperature
maintained
HS
Analysis
Flavonolignans
simultaneous
free
nonconjugated
achieved
It
detail
elsewhere
flavonolignan
Calibration
linear
range
analytes
intraand
interday
accuracies
Genotyping
carrier
deficient
alleles
gene
allele
polymerase
chain
reaction
method
Heim
Meyer
involves
amplification
segments
locus
chromosome
primers
match
common
mutant
genes
Leukocyte
deoxyribonucleic
extracted
freshly
spin
kit
QIAmp
Qiagen
Valencia
Taq
deoxynucleotide
triphosphates
buffers
PerkinElmer
Norwalk
CT
thermocycler
model
GeneAmp
PCR
employed
Data
Statistical
Analyses
Pharmacokinetic
parameters
AUCs
noncompartmental
analyses
Kinetica
Fisher
Waltham
MA
linearlog
trapezoidal
calculate
Two
tailed
paired
t
tests
conducted
detect
difference
preand
GraphPad
Prism
Software
La
Jolla
For
parameter
level
statistical
significance
phenotyping
metrics
bioequivalence
approach
absence
relevant
interaction
concluded
if
bounds
boundary
instead
because
Food
considers
latter
conservative
industry
Ring
Tomalik
Scharte
U
Services
Evaluation
CDER
Probe
exhibit
betweenand
limits
could
false
conclusion
statistically
Chien
Based
estimate
correlation
repeated
measures
size
eight
would
least
power
demonstrate
geometric
mean
ratio
fall
Results
Nine
men
six
women
aged
years
weight
kg
completed
entire
protocol
discontinued
violations
participant
withdrew
personal
reason
No
experienced
unanticipated
adverse
event
abnormalities
Concentrations
Unconjugated
revealed
had
measurable
it
h
Table
indicate
corresponding
There
differences
ratios
metric
similar
defined
acceptance
criteria
further
investigate
two
slightly
outside
relationship
examined
When
plotted
against
changes
observed
=
r
Fig
correlations
correlated
constituent
metabolic
pre
versus
timeconcentration
infinity
assured
respective
mediated
Interactions
Discussion
show
does
According
CIs
lie
demonstrated
essentially
unchanged
Our
suggest
typical
dosing
regimens
inhibitory
inductive
confirmed
monitoring
consistent
those
recently
should
note
side
abnormal
supplementation
Parameters
fell
threshold
signal
concern
investigated
isoenzyme
Among
appears
isoform
sensitive
microsome
incubation
fold
assessments
others
supplemented
whether
increase
caused
we
diastereomers
levels
neither
nor
appeared
increases
observation
agreement
suggesting
relatively
low
prostate
cancer
comparative
purposes
expressed
molar
mol
wt
only
Clearly
far
greatly
below
likely
explains
induction
detected
speculate
might
become
when
treated
sufficiently
formulations
complexes
phytosomes
recognize
matter
peripheral
Nevertheless
TABLE
Summary
Pre
Postexposure
Value
Equivalency
Test
Geometric
Mean
Ratio
mcg
inf
Correlation
regarded
suspect
terms
participating
attained
routine
particular
suggests
unlikely
Some
discrepancy
explained
physiologically
attainable
One
disposition
metronidazole
intestinal
glycoprotein
Rajnarayana
contradictory
result
findings
remains
unclear
what
substrates
indinavir
ranitidine
digoxin
Similarly
showed
incorporated
different
debrisoquine
chlorzoxazone
nifedipine
rosuvastatin
influenced
immunodeficiency
infected
irinotecan
darunavir
Molto
majority
enzyme
limitation
suggestion
Schrieber
Indeed
compared
Decreased
conjugation
extensive
enterohepatic
cycling
well
comparator
difficult
make
interpretations
earlier
exposures
noncirrhosis
cirrohsis
cohorts
considerably
increased
certain
states
pronounced
able
Another
regimen
represent
initial
perhaps
end
but
included
extrapolation
requires
caution
population
factor
considered
current
genotype
Recently
angiotensin
receptor
antagonist
losartan
its
predominantly
males
employing
Han
decreased
individuals
*
impairment
contributed
metabolizer
another
important
aspect
future
such
cannot
necessarily
An
extension
type
summary
little
concurrently
currently
metabolized
Acknowledgments
authors
thank
Madaus
providing
Authorship
Contributions
Participated
research
design
Conducted
experiments
Contributed
new
reagents
analytic
tools
Performed
Wrote
writing
manuscript
References
Rietbrock
Weyhenmeyer
Bocker
RH
Beckurts
KT
Lang
W
Hunz
Inhibitory
Pharmacol
Toxicol
SJ
Oberlies
NH
DJ
Paine
MF
warfarin
achievable
Exp
Ther
BJ
HJ
JS
LC
Chromatogr
Analyt
Technol
Biomed
Life
Sci
JY
Lucksiri
Ernest
CS
nd
Gorski
JC
Wrighton
SA
Hall
SD
Stochastic
prediction
ketoconazole
YH
Chin
YW
Kim
YG
Herb
focus
transporters
Arch
Pharm
Res
JW
Shon
JH
Shin
Yeo
CW
Zhou
HH
Song
JG
Effect
Shelton
Jordan
Koval
Forrest
Reichman
Morse
G
Coadministration
TW
Gustafson
DL
Su
LJ
Zirrolli
JA
Crighton
Harrison
GS
Pierson
AS
Agarwal
Glode
LM
phytosome
Invest
New
Drugs
Jetter
Luck
Mengs
Planta
Med
FP
Common
uncommon
reactions
related
toxicity
Chem
Hubbard
Williams
DK
Thaden
Tong
Y
Gentry
WB
Breen
Carrier
Cheboyina
Assessing
comparison
black
cohosh
rifampin
clarithromycin
Clin
Barone
GW
Yates
CR
PF
Cimicifuga
racemosa
humans
Gardner
SF
Khan
IA
Edwards
Shah
phenotypes
Citrus
aurantium
Echinacea
purpurea
saw
palmetto
Swain
Hartsfield
Battu
SK
herb
goldenseal
kava
wort
Mol
Nutr
Guo
Chen
Tan
ZR
Chinese
Eur
UA
metabolisers
allelespecific
Lancet
Kohli
Ali
Reassessing
Altern
Rev
NP
RF
Stavropoulos
Herman
Hastie
BA
preliminary
self
pain
experience
postoperative
analgesia
Shaw
nomenclature
why
matters
Integr
Cancer
HW
Influence
rat
man
Arzneimittelforschung
Ooyen
Lynch
Blumenthal
herbal
rise
th
consecutive
year
turmeric
jump
natural
channel
HerbalGram
Silybin
basic
practice
World
Gastroenterol
Wilson
Clarke
Foster
Walker
Rachlis
DeGroot
N
Montori
VM
Gold
Phillips
randomized
controlled
meta
Valle
Miranda
Cedeno
Negredo
Clotet
ritonavir
HIV
Antimicrob
Agents
Chemother
carcinogenesis
CAS
rats
mice
Feed
Studies
Natl
Tech
Rep
Ser
TD
Le
Sadr
Naud
Leblond
FA
Pichette
Himmelfarb
ESRD
impairs
nonrenal
fexofenadine
Am
Soc
Nephrol
Formentini
Burstein
AH
Alfaro
Jagannatha
Falloon
Reddy
Vidyasagar
Krishna
DR
pretreatment
BN
Srinivas
Kumar
YS
YM
Metabol
Interact
Patterson
BE
Mitchell
Vandenbranden
Gillespie
Bedding
AW
Jewell
Payne
CD
Forgue
ST
Eckstein
tadalafil
Hawke
RL
Wen
Smith
PC
KR
Wahed
Belle
SH
Afdhal
Navarro
VJ
Meyers
CM
Differences
Vourvahis
Fried
MW
Kashuba
AD
correlates
caspase
medicines
Pharmacokinet
Goosen
TC
Kent
UM
Hollenberg
inactivates
cytochromes
inhibits
glucuronosyltransferases
Kinzig
Schippers
Skott
Sorgel
Klaassen
T
Kasel
Harlfinger
Doroshyenko
O
Frank
propiverine
Guidance
Industry
Interaction
Implications
Dosing
Labeling
Recommendations
Rockville
MD
Baker
Zhao
Rudek
Guchelaar
Nortier
Sparreboom
Gelderblom
Ramachandran
Komoroski
Zhang
Schiff
PL
Strom
decreases
uridine
diphosphoglucuronosyl
transferase
hepatocyte
cultures
Hamman
Huang
SM
Lesko
Hypericum
perforatum
Naue
Lutz
Bonengel
Dresen
Auwarter
Cocktail
development
effective
analytical
procedure
pilot
genotyping
regulation
expression
impact
genetic
variation
KD
Patrick
KS
Modriansky
Dvorak
Rohovsky
Ulrichova
Simanek
Anzenbacher
congeners
microsomal
Phytother
Address
correspondence
Dr
SW
Archer
Road
RM
PG
FL
mail
jmarkowitz
@
cop
ufl
edu
